JULIA FRIEND: Open Payments
NPI 1861910572 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 39 payments from 9 companies in 2025. Trend: 2023 $297 · 2024 $612 · 2025 $721
Food & beverage: $611Education: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $223 |
| Janssen Biotech, Inc. | 11 | $204 |
| GENZYME CORPORATION | 5 | $129 |
| UCB, Inc. | 2 | $46 |
| Amgen Inc. | 2 | $36 |
| Galderma Laboratories, L.P. | 2 | $29 |
| Botanix SB Inc | 1 | $20 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $20 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $15 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, Bimzelx, OTEZLA, NEMLUVIO, SOFDRA, ILUMYA.
Industry payments across PA — which companies pay providers there.
